Evidence map›Paper›PMID 35110252›Full record

ArticleTurkish thoracic journal2021

The Role of Pneumococcal Pneumonia among Community-Acquired Pneumonia in Adult Turkish Population: TurkCAP Study.

Esin Şenol, Aykut Çilli, Hakan Günen, Alper Şener, Rıdvan Dumlu, Ayşe Ödemiş, Ayşe Füsun Topçu, Yeşim Yıldız, Rahmet Güner, Ayhan Özhasenekler and 19 more

Open access · diamondAbstract read
In one paragraph

Article in Turkish thoracic journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 1 country.

Esin ŞenolDepartment of Infectious Diseases, Gazi University, Faculty of Medicine, Ankara, Turkey.
Aykut ÇilliDepartment of Pulmonary Diseases, Akdeniz University, Faculty of Medicine, Antalya, Turkey.
Hakan GünenDepartment of Pulmonary Diseases, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.
Alper ŞenerDepartment of Infectious Diseases and Clinical Microbiology, 18 Mart University, Faculty of Medicine, Çanakkale, Turkey.
Rıdvan DumluDepartment of Infectious Diseases and Clinical Microbiology, 18 Mart University, Faculty of Medicine, Çanakkale, Turkey.
Ayşe ÖdemişDepartment of Pulmonary Diseases, Akdeniz University, Faculty of Medicine, Antalya, Turkey.
Ayşe Füsun TopçuDepartment of Pulmonary Diseases, Dicle University, Faculty of Medicine, Diyarbakır, Turkey.
Yeşim YıldızDepartment of Infectious Diseases and Clinical Microbiology, Mardin State Hospital, Mardin, Turkey.
Rahmet GünerDepartment of Infectious Diseases and Clinical Microbiology, Ankara Atatürk Training and Research Hospital, Ankara, Turkey.
Ayhan ÖzhaseneklerDepartment of Emergency Medicine, Ankara Atatürk Training and Research Hospital, Ankara, Turkey.
Birsen MutluDepartment of Infectious Diseases, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.
Nurdan KöktürkDepartment of Pulmonary Diseases, Gazi University, Faculty of Medicine, Ankara, Turkey.
Nurgül SevimliDepartment of Pulmonary Diseases, Gazi University, Faculty of Medicine, Ankara, Turkey.
Nurcan BaykamDepartment of Infectious Diseases and Clinical Microbiology, Hitit University, Faculty of Medicine, Çorum, Turkey.
Derya YaparDepartment of Infectious Diseases and Clinical Microbiology, Hitit University, Faculty of Medicine, Çorum, Turkey.
Selami EkinDepartment of Pulmonary Diseases, Yüzüncü Yıl University, Faculty of Medicine, Van, Turkey.
Mehmet PolatlıDepartment of Pulmonary Diseases, Adnan Menderes University, Faculty of Medicine, Aydın, Turkey.
Şebnem Eren GökDepartment of Infectious Diseases and Clinical Microbiology, Bozok University, Faculty of Medicine, Yozgat, Turkey.
Oğuz KılınçDepartment of Pulmonary Diseases, Dokuz Eylül University, Faculty of Medicine, Izmir, Turkey.
Abdullah SayınerDepartment of Pulmonary Diseases, Ege University, Faculty of Medicine, Izmir, Turkey.
Ömer KaraşahinDepartment of Infectious Diseases and Clinical Microbiology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Çağlar ÇuhadaroğluDepartment of Pulmonary Diseases and Sleep Disorder, Acıbadem Health Group Maslak Hospital, Istanbul, Turkey.
Ayşe Sesin KocagözDepartment of Infectious Diseases and Clinical Microbiology, Acıbadem Health Group Maslak Hospital, Istanbul, Turkey.
Turhan ToganDepartment of Infectious Diseases and Clinical Microbiology, Başkent University Konya Hospital, Konya, Turkey.
Hüseyin ArpağDepartment of Pulmonary Diseases, Sutcu Imam University, Faculty of Medicine, Kahramanmaraş, Turkey.
Hakan KatıDepartment of Infectious Diseases, Gazi University, Faculty of Medicine, Ankara, Turkey.
İftihar KöksalDepartment of Infectious Diseases, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey.
Firdevs AksoyDepartment of Infectious Diseases, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey.
Canan HasanoğluDepartment of Pulmonary Diseases, Ankara Atatürk Training and Research Hospital, Ankara, Turkey.
Ankara Atatürk Eğitim ve Araştırma Hastanesi · TRGazi University · TRBozok Universitesi · TRErzurum Regional Training and Research Hospital · TRMardin Artuklu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the rate of pneumococcal pneumonia (PP) among patients with community-acquired pneumonia (CAP) in Turkey and to investigate and compare features of PP and non-PP CAP patients. MATERIAL AND

methodsThis multicenter, non-interventional, prospective, observational study included adult CAP patients (age ≥ 18 years). Diagnosis of PP was based on the presence of at least 1 positive laboratory test result for Streptococcus pneumoniae (blood culture or sputum culture or urinary antigen test [UAT]) in patients with radiographic findings of pneumonia.

resultsFour hundred sixty-five patients were diagnosed with CAP, of whom 59 (12.7%) had PP. The most common comorbidity was chronic obstructive pulmonary disease (30.1%). The mean age, smoking history, presence of chronic neurological disease, and CURB-65 score were significantly higher in PP patients, when compared to non-PP patients. In PP patients, 84.8% were diagnosed based ony on the UAT. The overall rate of PP patients among CAP was calculated as 22.8% considering the UAT sensitivity ratio of 63% (95% confidence interval: 45-81). The rate of intensive care treatment was higher in PP patients (P = .007). While no PP patients were vaccinated for pneumococcus, 3.8% of the non-PP patients were vaccinated (P = .235). Antibiotic use in the preceding 48 hours was higher in the non-PP group than in the PP group (31.8% vs. 11.1%, P = .002). The CURB-65 score and the rate of patients requiring inpatient treatment according to this score were higher in the PP group.

conclusionThe facts that PP patients were older and required intensive care treatment more frequently as compared to non-PP patients underline the burden of PP.

Identifiers

PMID35110252
PMCPMC8975353
OpenAlexW3179384986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.